Studies on amphibian yolk. VII. Serum phosphoprotein synthesis by vitellogenic females and estrogen-treated males of Xenopus laevis

1968 ◽  
Vol 46 (8) ◽  
pp. 953-959 ◽  
Author(s):  
R. A. Wallace ◽  
D. W. Jared

Female toads given 1000 units of human chorionic gonadotropin ovulated within 24 h and began to synthesize a phosphoprotein which appeared, but did not accumulate, in the serum (physiological half-life, 2 days). The period of synthesis lasted about 30 days, after which mature oocytes were once again observed in the ovary. Male toads given a single dose of 0.1–1.0 mg estradiol-17β also immediately began to synthesize a phosphoprotein. The rate of maximum synthesis and the length of time for the maximum to be reached were directly proportional to the amount of estrogen administered. The serum phosphoprotein in male toads, however, had a physiological half-life of approximately 40 days. Ovariectomized females produced a serum phosphoprotein with a physiological half-life similar to that of males. We therefore concluded that under normal conditions the circulating phosphoprotein produced by the liver of the female as a response to estrogen is accumulated by the vitellogenic ovary. The serum phosphoprotein is apparently a lipophosphoprotein complex from which at least one of the yolk proteins, phosvitin, may be derived.

Reproduction ◽  
2012 ◽  
Vol 144 (1) ◽  
pp. 77-81 ◽  
Author(s):  
M Saleh ◽  
M Shahin ◽  
W Wuttke ◽  
M Gauly ◽  
W Holtz

The present investigation addresses the pharmacokinetics of human chorionic gonadotropin (hCG), intramuscularly (i.m.) administered to goats. Nine pluriparous does of the Boer goat breed, 2–6 years of age and weighing 45–60 kg, were administered 500 IU hCG (2 ml Chorulon) deep into the thigh musculature 18 h after superovulatory FSH treatment. Blood samples were drawn from the jugular vein at 2 h intervals for the first 24 h, at 6 h intervals until 42 h, and at 12 h intervals until 114 h after administration. After centrifugation, plasma hCG concentrations were determined by electrochemiluminescence immunoassay. Pharmacokinetical parameters were as follows: lag time, 0.4 (s.e.m. 0.1) h; absorption rate constant, 0.34 (s.e.m. 0.002) h; absorption half-life, 2.7 (s.e.m. 0.5) h; elimination rate constant, 0.02 (s.e.m. 0.002) h; biological half-life, 39.4 (s.e.m. 5.1) h; and apparent volume of distribution, 16.9 (s.e.m. 4.3) l. The plasma hCG profile was characterized by an absorption phase of 11.6 (s.e.m. 1.8) h and an elimination phase of 70.0 (s.e.m. 9.8) h, with considerable individual variation in bioavailability and pharmacokinetical parameters. Biological half-life was negatively correlated (P<0.05) with peak concentration (r=−0.76), absorption rate constant (r=−0.78), and elimination rate constant (r=−0.87). The results indicate that after rapid absorption, hCG remains in the circulation for an extended period. This has to be taken into account when assessing the stimulatory response to hCG treatment on an ovarian level.


Author(s):  
Andrea Natale ◽  
Mauro Busacca ◽  
Massimo Candiani ◽  
Luciano Gruft ◽  
Stefano Izzo ◽  
...  

1983 ◽  
Vol 57 (2) ◽  
pp. 421-424 ◽  
Author(s):  
V. TOSCANO ◽  
R. BALDUCCI ◽  
M. V. ADAMO ◽  
M. L. MANCA BITTI ◽  
F. SCIARRA ◽  
...  

2016 ◽  
Vol 22 (1) ◽  
Author(s):  
Kılıç Çiğdem ◽  
Mehmet Metin Altay ◽  
Tuğba Kınay ◽  
Metin Kaplan ◽  
Serap Fırtına Tuncer ◽  
...  

<p>Objectives: To evaluate the impact of the uterine artery Doppler values and the change of β-Human chorionic gonadotropin (β-HCG) levels from day 0 to day 4 for prediction of the success of single dose methotrexate treatment in tubal pregnancy cases. <br />Study Design: 50 patients with tubal pregnancy were included the prospective study. The location and size of ectopic pregnancy, bilateral uterine artery pulsed color doppler imaging was examined by ultrasonography and serum β-HCG levels were measured on day 0, 4, 7 of treatment. Success was defined as decrease of β-HCG level &lt;10 mIU/mL with single dose methotrexate treatment. Multiple dose methotrexate treatment and surgical treatment were considered as treatment failure.<br />Results: 32 patients (64%) treated with single dose methotrexate, 14 patients (28%) treated with multiple dose methotrexate, and 4 patients (8%) treated with surgery. In the group with β-HCG level decrease &gt; 15.04% on day 4, single-dose methotrexate therapy were 3.82 times more successful than the group without &gt; 15.04% β-HCG decrease. However, no significant alteration of uterine artery Doppler measurements was determined on the same days.<br />Conclusion: Reduction rate in the β-HCG level on day 4 of treatment can be used in determination the success of single-dose methotrexate therapy. <br /><br /></p>


Sign in / Sign up

Export Citation Format

Share Document